ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Monocytes/macrophages"

  • Abstract Number: 1862 • ACR Convergence 2024

    Folate Receptor β CAR-Tregs Induce Monocyte Apoptosis and Immune Polarization: Potential for Therapeutic Application in Rheumatoid Arthritis

    Xiangni Wu1, Pin-I Chen2, Magdiel Pérez Cruz3, Kent Jensen3 and Everett Meyer3, 1UMKC, KANSAS CITY, MO, 2Department of Medicine, Division of Blood and Bone Marrow Transplantation and Cell Therapy, Stanford University School of Medicine, Stanford, CA, USA., Sunnyvale, CA, 3Department of Medicine, Division of Blood and Bone Marrow Transplantation and Cell Therapy, Stanford University School of Medicine, Stanford, CA, USA., Stanford

    Background/Purpose: Rheumatoid arthritis (RA) affects approximately 1.3 million adults in the United States, causing significant morbidity and economic burden. Current treatments reduce inflammation and slow…
  • Abstract Number: 0073 • ACR Convergence 2024

    Self or Bacteria-reactive Th17 Expand from Conventional and Regulatory T Cells in Parabacteroides Goldsteinii Gnotobiotic Arthritic SKG Mice, in Context of Interferon-driven Synovial Inflammatory Macrophages and Reduced Bacterial Immune Regulation

    Benjamin Cai1, Zewen Kelvin Tuong2, Mark Morrison1, Anne-Sophie Bergot1 and Ranjeny Thomas3, 1Frazer Institute, University of Queensland, Brisbane, Australia, 2Child Health Research Centre, University of Queensland, South Brisbane, Queensland, Australia, 3University of Queensland, Brisbane, Australia

    Background/Purpose: In ankylosing spondylitis, spondyloarthritis (SpA) is often associated with gut inflammation. The strong genetic association with HLA-B27 and expanded CD8 TCR public clonotypes implicate…
  • Abstract Number: 2247 • ACR Convergence 2024

    Pro-inflammatory Monocytes and CD11c Expression in ACPA Positive Individuals with Arthralgia and Their Associations with Subclinical Synovitis Preceding the Onset of Arthritis

    Klára Prajzlerová1, Olga Kryštufková2, Petra Hánová1, Nora Růžičková2, Hana Hulejová1, Jiří Vencovský2, Ladislav Šenolt2 and Mária Filková2, 1Institute of Rheumatology, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic

    Background/Purpose: Autoantibodies, e.g., against citrullinated proteins (ACPA), increase the risk of clinical arthritis and can be detected years before rheumatoid arthritis (RA) onset. EULAR's definition…
  • Abstract Number: 0890 • ACR Convergence 2024

    Pervasive Inflammation Poisons Hematopoiesis and Drives Clonal Dominance in VEXAS Syndrome

    Corrado Campochiaro1, Molteni raffaella2, Martina Fiumara3, Alessandro Tomelleri4, Elisa Diral5, Davide Stefanoni6, Angelica Varesi6, Alessandra Weber7, Roberta Alfieri8, Luisa Albano7, Maddalena Panigada6, Eleonora Cantoni6, Daniele Canarutto9, Luca Basso-Ricci10, Pamela Quaranta7, Angelo D’Alessandro11, Gregorio Bergonzi12, Marco Matucci-Cerinic13, Raffaella Di Micco3, Alessandro Aiuti3, Fabio Ciceri12, Ivan Merelli3, Lorenzo Dagna14, Serena Scala3, Simone Cenci6, Luigi Naldini3, Samuele Ferrari3 and Giulio Cavalli15, 1IRCCS San Raffaele Hospital. Vita-Salute San Raffaele University, Milan, Milan, Italy, 2Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy, Milan, Italy, 3San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy, Milan, Italy, 4Unit of Immunology, Allergology and Rare Diseases, IRCCS Ospedale San Raffaele, Milano, Italy, 5Unit of Haematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milan, Italy, Milan, Lombardia, Italy, 6Division of Genetics and Cell Biology, IRCCS San Raffaele Scientific Institute, Milan, Italy, Milan, Lombardia, Italy, 7San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy, 8Institute for Biomedical Technologies, National Research Council, Segrate, Italy, 9Pediatric Immunohematology Unit and BMT Program, IRCCS San Raffaele Scientific Institute, Milan, Italy, 10San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milano, Italy, 11Department of Biochemistry and Molecular Genetics, University of Colorado Denver - Anschutz Medical Campus, Autora, CO, 12Unit of Haematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Milan, Italy, Milan, Italy, 13University San Raffaele Milano, Milano, Milan, Italy, 14Ospedale San Raffaele, Milano, Italy, 15Vita-Salute San Raffaele University, Milan, Italy

    Background/Purpose: VEXAS syndrome is an adult-onset, X-linked, life-threatening, autoinflammatory and hematological disease caused by somatic mutation in UBA1 gene. Our study aims at uncovering pathophysiology…
  • Abstract Number: 2290 • ACR Convergence 2024

    Umbilical Cord-derived Mesenchymal Stem Cells Suppress Sjogren’s Syndrome Pathology

    Yukitomo Hagiwara1, Goh Murayama2, Taiga Kuga2, Yujin Nishioka2, Takumi Saito2, Yu Yamaji2, Tomoko Miyashita2, Makio Kusaoi3, Ken Yamaji2 and Naoto Tamura2, 1Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan, 2Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, 3Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Bunkyo, Tokyo, Japan

    Background/Purpose: Primary Sjögren's syndrome (pSS) is characterized by lymphocytic infiltration of the salivary and lacrimal glands, leading to functional loss and gradually causing dry mouth…
  • Abstract Number: 0925 • ACR Convergence 2024

    Macrophages Produce Bone Anabolic Factors in Settings of Inflammation-Induced Bone Formation

    Jia (Sijia) Chen1, Megan Hanlon2, Catherine Manning3, Susan MacLauchlan1, Paul Hoover4, Christian Jacome-Galarza5 and Ellen Gravallese6, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women’s Hospital, Boston, MA, 3Brigham and Women's Hospital, Dedham, MA, 4Brigham and Women's Hospital, SWAMPSCOTT, MA, 5Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6Brigham and Women's Hospital, Harvard Medical School, Chestnut Hill, MA

    Background/Purpose: Understanding the pathogenesis of inflammation-induced pathologic bone formation remains a significant challenge in spondyloarthritis patients. We thought to uncover the pivotal events driving the…
  • Abstract Number: 2327 • ACR Convergence 2024

    Differential Quantitative Profile of Myeloid Derived Suppressor Cells and Monocyte Subsets Relate to Clinical Phenotype and Disease Activity in Psoriatic Arthritis Patients

    Jennifer Balderas Miranda1, Jiram Torres Ruiz2, Guillermo Guaracha Basañez3, Virginia Pascual Ramos4, Beatriz Alcalá-Carmona5, Yatzil Reyna-Juárez5, María José Ostos-prado5, Nancy R Mejía-Domínguez5, Guillermo Juarez-Vega6 and Diana Gomez-martin7, 1Universidad Nacional Autónoma de México, Ciudad de México, Mexico, 2INCMNSZ, Mexico, Federal District, Mexico, 3Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirón", Mexico City, Mexico, 4Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Federal District, Mexico, 5Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Distrito Federal, Mexico, 6Red de Apoyo a la Investigación, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán and Universidad Nacional Autónoma de México, Mexico City, Distrito Federal, Mexico, 7INCMNSZ, Mexico City, Federal District, Mexico

    Background/Purpose: The innate immune system not only participates in PsA pathogenesis but may also counteract with immunomodulatory elements. Proinflammatory and repairing roles according to monocyte…
  • Abstract Number: 0062 • ACR Convergence 2023

    Differential Metabolic Profiles, Activation and Circadian Dynamics in Rheumatoid Arthritis and Psoriatic Arthritis Circulatory Monocytes

    Alyssa Gilmore1, Success Amaechi2, Megan Hanlon3, Dumitru Anton4, Carl Orr5, Viviana Marzaioli6, Douglas Veale7 and Ursula Fearon1, 1Trinity College Dublin, Dublin, Ireland, 2Trinity College Dublin, Mullingar, Ireland, 3Molecular Rheumatology, Dublin, Ireland, 4Molecular Rheumatology Department, Trinity Biomedical Sciences Institute, Trinity College Dublin, EULAR Centre for Arthritis and Rheumatic Diseases, St Vincent University Hospital, University College Dublin, Dublin, Ireland, 5Saint Vincent's University Hospital, Dublin, Ireland, 6Trinity College Dublin and University College Dublin, Dublin, Ireland, 7St.Vincent's University Hosp, Dublin, Ireland

    Background/Purpose: While Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) share many features, they are distinct in clinical presentation and molecular profile. As monocytes are crucial…
  • Abstract Number: 0916 • ACR Convergence 2023

    Upregulation of the M-CSF Receptor on Non-Classical Monocytes from SLE Patients as an Indicator for Premature Monocyte Aging

    Markus Zeisbrich1, Stephanie Finzel2, Nils Venhoff1 and Reinhard Voll1, 1University Medical Center Freiburg, Freiburg, Germany, 2Department of Rheumatology and Clinical Immunology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany

    Background/Purpose: Circulating monocytes are divided into three subsets: classical, intermediate, and non-classical monocytes. Monocytes egress from the bone marrow as classical monocytes and develop into…
  • Abstract Number: 1588 • ACR Convergence 2023

    Monocyte-derived Macrophages Accumulate in the Lungs in anti-MDA5+ Dermatomyositis with RP-ILD: Proinflammatory and Profibrotic Phenotype Revealed by Single-cell RNA Sequencing

    Xiaoya Pei1, Jia Shi2, Yangzhong Zhou2, Xiao Zhang2, Xiaoman Wang1, Mingwei Tang2, Shuang Zhou2, chanyuan wu2, Jinmin Peng3, Mengtao Li4, xiaofeng Zeng2, Jun Liu5, Houzao Chen1 and Qian Wang2, 1State Key Laboratory of Medical Molecular Biology, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 3Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, 4Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 5State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China

    Background/Purpose: Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (anti-MDA5+ DM) is a rare inflammatory autoimmune disease with impressively life-threatening rapid progressive interstitial lung disease (RP-ILD). The mechanism…
  • Abstract Number: 1714 • ACR Convergence 2023

    Aberrant Myeloid Populations in the TNF-Transgenic Model of Pulmonary Hypertension Overexpress Interferon Pathways and Are Driven by TNFR1 Signaling

    Gaochan Wang1, Qingfu Xu2, Stacey Duemmel1 and Benjamin Korman1, 1University of Rochester, Rochester, NY, 2University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Pulmonary hypertension (PH) is a severe, progressive disorder characterized by elevated pulmonary artery pressures, right ventricular hypertrophy, and increased mortality. We previously demonstrated that…
  • Abstract Number: 1736 • ACR Convergence 2023

    The Effect of Resolvin E1 and Resolvin D1 Specialised Pro-resolving Mediators on the Inhibition of Osteoclastogenesis

    Patricia Riedlova1, Kieran Woolcock2, Cecilia Ansalone2 and Carl Goodyear2, 1University of Glasgow - School of Infection & Immunity, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: Osteoclasts (OCs) are multinucleated bone-resorbing cells playing a key role in rheumatoid arthritis (RA). Under physiological conditions, OCs are in balance with bone-forming osteoblasts,…
  • Abstract Number: 2149 • ACR Convergence 2023

    Biologic IRL201805 Drives Differential Cell-contact and Metabolism Transcriptional Profiles in Monocytes from RA Patients Compared to Healthy Donors

    Yuriko Yamamura1, Kieran Woolcock2, Valerie Corrigall3, Lara Ravanetti4, Jorge De Alba4, Roly Foulkes5, Paul Eggleton6 and Carl Goodyear2, 1School of Infection & Immunity, University of Glasgow, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom, 3Revolo Biotherapeutics, Tadworth, United Kingdom, 4Revolo Biotherapeutics, London, United Kingdom, 5Revolo Biotherapeutics, Slough, United Kingdom, 6Revolo Biotherapeutics, Exeter, United Kingdom

    Background/Purpose: IRL201805 is a novel biologic derived from Binding Immunoglobulin Protein (BiP) that has been developed for the treatment of Rheumatoid arthritis (RA) (P Eggleton,…
  • Abstract Number: 2150 • ACR Convergence 2023

    Novel Biologic IRL201805 Inhibits Osteoclastogenesis in Monocytic Cells from RA Patients

    Yuriko Yamamura1, Valerie Corrigall2, Lara Ravanetti3, Jorge De Alba3, Roly Foulkes4, Paul Eggleton5 and Carl Goodyear6, 1School of Infection & Immunity, University of Glasgow, Glasgow, United Kingdom, 2Revolo Biotherapeutics, Tadworth, United Kingdom, 3Revolo Biotherapeutics, London, United Kingdom, 4Revolo Biotherapeutics, Slough, United Kingdom, 5Revolo Biotherapeutics, Exeter, United Kingdom, 6University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: In Rheumatoid arthritis (RA), osteoclasts derived from CD14+ Monocytes are associated with a risk of progressive bone and joint destruction, which fundamentally impacts quality-of-life.…
  • Abstract Number: 2232 • ACR Convergence 2023

    Guselkumab, an IL-23p19 Subunit–specific Monoclonal Antibody, Is Able to Bind CD64+ Myeloid Cells, Potently Neutralize IL-23 Produced from the Cells, and Mediate Internalization of IL-23

    Dennis McGonagle1, raja atreya2, Maria Abreu3, James Krueger4, Kilian Eyerich5, Robert Bissonnette6, Kacey Sachen7, Carrie Greving7, Brian Stoveken8, Deepa Hammaker7, Kristin Leppard8, John Hartman8, Phuc Bao7, Eilyn Lacy8, Indra Sarabia7, Janise Deming7, Matthew Duprie8, Joseph Brown7, Christopher T Ritchlin9, Iain McInnes10, Matthieu Allez11 and Anne Fourie7, 1Leeds Biomedical Research Centre, University of Leeds, Leeds, United Kingdom, 2Erlangen University Hospital, Friedrich-Alexander-Univrsität Erlangen-Nürnberg, Erlangen, Germany, 3University of Miami, Leonard Miller School of Medicine, Miami, FL, 4The Rockefeller University, Laboratory for Investigative Dermatology, New York, NY, 5Medical Center, University of Freiburg; Karolinska Institute, Department of Medicine - Division of Dermatology and Venereology, Stockholm, Sweden, 6Innovaderm Research Inc, Medical Director, Montréal, QC, Canada, 7Janssen Research and Development, LLC, Immunology, San Diego, CA, 8Janssen Research & Development, LLC, Therapeutics Discovery, Spring House, PA, 9University of Rochester Medical School, Allergy, Immunology & Rheumatology Division, Canandaigua, NY, 10University of Glasgow, Glasgow, United Kingdom, 11Hôpital Saint-Louis, Université Paris Cité, Paris, France

    Background/Purpose: Monoclonal antibodies (mAbs) targeting the interleukin (IL)-23p19 subunit are effective in treating psoriatic disease; however, their molecular attributes may translate to differences in clinical…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 6
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology